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An unusual cause of high density radiological opacities
Abstract
Introduction: Metallic mercury poisoning through intravenous injection is rare, especially as part of a suicide attempt. Diagnosis 
and treatment of the disease are challenging as clinical features are not specific.
Material and metods: A 41-year-old male presented with dyspnea, fatigue, loss of weight, and loss of appetite over two months. 
Routine radiological examination by chest X-ray and CT showed randomly distributed high density opacities with Hounsfield units 
(HU) around 500 HU all over the body. The diagnosis was then confirmed with a urinary mercury concentration of > 1000 mcg/24 h.
Results: The patient’s clinical condition was getting worse in spite of chelation therapy and hemodialysis. The patient eventually 
died because of respiratory failure.
Conclusion: Early diagnosis and appropriate treatment are critical for intravenous mercury poisoning especially because there are 
no specific signs or symptoms. There should be a high level of suspicion in drug abusers. Treatment should involve the combined 
use of chelating agents and other treatments such as hemodialysis and plasma exchange in advanced clinical settings.
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Introduction
High density opacities on chest X-ray are an 
infrequent finding and are highly nonspecific. 
When such a radiological picture is encountered the 
differential diagnosis includes pulmonary alveolar 
microlithiasis, pulmonary hemosiderosis, metal 
poisoning, barium aspiration, pellet injury, and 
possible remnants of contrast used for lymphangio-
graphy or myelography. However, a thorough history 
taking, physical examination and other supportive 
investigations will help in achieving a proper dia-
gnosis. Though uncommon, mercury poisoning can 
be seen in patients who are frequent drug abusers as 
well as in individuals working in the manufacturing 
of industrial chemicals, paints, explosives, batteries, 
thermometers, electronic instruments, etc.
Mercury exists in elemental, inorganic, and 
organic forms. Elemental mercury causes pul-
monary, neurologic and nephrotoxic injury and 
its poisoning results most commonly from vapor 
inhalation as it is absorbed (80%) throughout the 
lungs [1]. Poisoning due to intravenous injection 
of mercury usually occurs in connection with 
attempted suicide, by accident, or in drug addicts 
exploring new ways to become intoxicated [2].
Case details
A 41-year-old male presented with compla-
ints of breathlessness and cough with watery 
expectoration for the past 2 months. He also 
complained of loss of appetite and loss of weight 
(around 6–7 kg in 2 months). He was a painter 
by occupation with no known comorbidities. He 
was a chronic smoker and alcoholic with events 
of binge drinking for the past 15 years. He also 
had a history of recurrent IV drug abuse in the last 
6 months and it had increased in frequency over 
the past two weeks before presenting to emergency.
On examination, the patient was conscious, 
oriented, and afebrile. The patient had a blood 
pressure of 106/86 mm Hg, a pulse rate of 106/min, 
a respiratory rate of 26 cycles/min, and saturation 
was 93% in room air that improved to 96–98% with 
2 L oxygen supplementation with nasal prongs. 
Puncture marks along with thrombosed veins were 
seen in the right antecubital fossa extending on to 
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Figure 1. Puncture marks with thrombosed veins over right cubital 
fossa extending on to forearm
Figure 2. Chest X-ray showed multiple punctate and amorphous opa-
cities of metallic densities noted in bilateral lung fields
the forearm (Figure 1). Chest auscultation revealed 
bilateral normal vesicular breath sounds. There 
were no signs and symptoms of other organ involve-
ment. Blood urea, serum creatinine, and urine 
analysis were normal. Arterial blood gas analysis 
(ABG) showed a pH of 7.48, a pCO2 of 24 mm Hg, 
HCO3 of 23 mmoL/L, and a PO2 of 73 mm Hg which 
were all suggestive of respiratory alkalosis. 
Chest X-ray showed multiple punctate and 
amorphous opacities of metallic densities noted 
in bilateral lung fields (predominantly in the 
lower lobes) and overlying the cardiac silhouet-
te (Figure 2). An X-ray of the abdomen showed 
similar opacities over the liver, kidneys, and dor-
so-lumbar spine. A lateral radiograph of the skull 
was found to be normal. CT of the chest showed 
multiple diffusely distributed metallic densities 
in bilateral lungs, the pericardium, liver, and 
kidneys as well as in multiple vertebral bodies 
and foramina (Figure 3). These features were 
compared with similar scenarios in literature 
and thus, IV mercury poisoning was suspected 
[3–7]. CT Hounsfield unit (HU) values of the high 
density opacities were 179 to 1065 (mean 527 HU, 
median 566 HU). Hence, 24 hour urine mercury 
(ICP-MS) was measured and was found to be 
> 1000 mcg/24 h. The patient was prescribed the 
chelating agent penicillamine given at doses of 
500 mg orally every 6 hours in combination with 
pyridoxine (vitamin B6) in doses of 20 mg/day. 
The patient’s condition was worsening in spite of 
chelation therapy hence hemodialysis and plasma 
exchange were used. Unfortunately, the patient’s 
condition deteriorated and  he ultimately died 
due to respiratory failure.
Discussion
Elemental mercury, when injected intraveno-
usly, can cause widely varying presentations. It can 
be asymptomatic in some patients while causing 
respiratory failure, kidney damage, liver damage, 
neurologic symptoms, and even death in others. 
Once mercury enters the bloodstream, it’s quickly 
distributed throughout the body, particularly in the 
lungs as its absorption through the lungs is 80% [8]. 
Due to its high water–metal interfacial tension and 
lack of bonding to other materials, mercury either 
takes the form of tiny spherules or coalesces when 
it enters the plasma. Because of gas exchange and 
the extensive capillary network of the lungs thro-
ugh which blood flows back to the heart, the lungs 
can easily become a depository for the exogenous 
mercury. Because of this reason, the lungs are often 
more seriously affected than the other organs when 
examined on imaging and can give rise to a distinc-
tive radiological appearance. In cases of intravenous 
self-administration in the forearm veins like in our 
case, aggregations of mercury at the site of injection 
may also be radiologically seen [9]. Radiologically 
small metallic spherules of different sizes scattered 
throughout the lungs or beaded chains along the 
pulmonary vasculature and other organs of the 
body can also be observed [10].  Mercury is mainly 
excreted from the body by the kidneys, but the rate 
of excretion is usually very slow and traces of mer-
cury can be seen on radiographs and in urine even 
two years after the index event [8].  The total body 
burden of mercury can be determined by assessing 
twenty-four hour urinary levels of mercury. This 
total will serve as a useful marker to determine the 
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Figure 3. CT chest showed multiple diffusely distributed metallic densities in bilateral lung, pericardium, liver, kidneys and multiple vertebral bodies 
and foramina
A B
C BD
need for chelation therapy and gauge the prognosis 
in some cases. Dimercaprol (BAL, British anti­Lewi­
site) or succimer, an orally administered analogue of 
BAL, are effective chelators utilised for treatment. 
Chelation therapy is the mainstay of treatment be-
cause these agents increase the urinary excretion 
of mercury [11]. Combined use of chelating agents 
and other treatments like hemodialysis and plasma 
exchange will enhance the elimination of mercury 
from the body in severe poisoning.
Conclusion
A clinician must take mercury poisoning into 
consideration when the imaging results shows ra-
diopaque deposits that are unexplainable as early 
diagnosis and treatment is critical. Findings in 
a patient’s history such as occupational exposure 
of mercury and drug abuse are very critical in the 
diagnosis of mercury poisoning and will affect the 
patient outcome significantly.
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